Sofpironium Bromide Gel, 15%

DRUG3 trials

Sponsors

Botanix Pharmaceuticals

Conditions

Axillary HyperhidrosisPrimary Axillary Hyperhidrosis

Phase 2

A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis

CompletedNCT03785587

Botanix PharmaceuticalsPrimary Axillary Hyperhidrosis

Start: 2018-12-21End: 2019-09-06Updated: 2023-03-14

Phase 3

A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis

CompletedNCT03627468

Botanix PharmaceuticalsPrimary Axillary Hyperhidrosis

Start: 2018-09-05End: 2020-01-27Updated: 2023-05-19

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

CompletedNCT03836287

Botanix PharmaceuticalsAxillary Hyperhidrosis

Start: 2020-10-09End: 2021-06-25Updated: 2024-06-06